These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 31477729)

  • 1. Tumor-reprogrammed resident T cells resist radiation to control tumors.
    Arina A; Beckett M; Fernandez C; Zheng W; Pitroda S; Chmura SJ; Luke JJ; Forde M; Hou Y; Burnette B; Mauceri H; Lowy I; Sims T; Khodarev N; Fu YX; Weichselbaum RR
    Nat Commun; 2019 Sep; 10(1):3959. PubMed ID: 31477729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKTR-214 immunotherapy synergizes with radiotherapy to stimulate systemic CD8
    Walker JM; Rolig AS; Charych DH; Hoch U; Kasiewicz MJ; Rose DC; McNamara MJ; Hilgart-Martiszus IF; Redmond WL
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32457127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of radiotherapy and vaccination overcomes checkpoint blockade resistance.
    Zheng W; Skowron KB; Namm JP; Burnette B; Fernandez C; Arina A; Liang H; Spiotto MT; Posner MC; Fu YX; Weichselbaum RR
    Oncotarget; 2016 Jul; 7(28):43039-43051. PubMed ID: 27343548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted in vivo expression of IFN-gamma-inducible protein 10 induces specific antitumor activity.
    Yang X; Chu Y; Wang Y; Zhang R; Xiong S
    J Leukoc Biol; 2006 Dec; 80(6):1434-44. PubMed ID: 16980511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-γ+IL-17+ polyfunctional T cells that mediate rejection of murine tumors.
    Marshall NA; Galvin KC; Corcoran AM; Boon L; Higgs R; Mills KH
    Cancer Res; 2012 Feb; 72(3):581-91. PubMed ID: 22158905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for Early Stage Anti-Tumor Immunity Elicited by Spatially Fractionated Radiotherapy-Immunotherapy Combinations.
    Johnsrud AJ; Jenkins SV; Jamshidi-Parsian A; Quick CM; Galhardo EP; Dings RPM; Vang KB; Narayanasamy G; Makhoul I; Griffin RJ
    Radiat Res; 2020 Dec; 194(6):688-697. PubMed ID: 33348372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy.
    Glodde N; Bald T; van den Boorn-Konijnenberg D; Nakamura K; O'Donnell JS; Szczepanski S; Brandes M; Eickhoff S; Das I; Shridhar N; Hinze D; Rogava M; van der Sluis TC; Ruotsalainen JJ; Gaffal E; Landsberg J; Ludwig KU; Wilhelm C; Riek-Burchardt M; Müller AJ; Gebhardt C; Scolyer RA; Long GV; Janzen V; Teng MWL; Kastenmüller W; Mazzone M; Smyth MJ; Tüting T; Hölzel M
    Immunity; 2017 Oct; 47(4):789-802.e9. PubMed ID: 29045907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete regression of experimental solid tumors by combination LEC/chTNT-3 immunotherapy and CD25(+) T-cell depletion.
    Li J; Hu P; Khawli LA; Epstein AL
    Cancer Res; 2003 Dec; 63(23):8384-92. PubMed ID: 14679000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.
    Oba T; Makino K; Kajihara R; Yokoi T; Araki R; Abe M; Minderman H; Chang AE; Odunsi K; Ito F
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity.
    Schmid D; Park CG; Hartl CA; Subedi N; Cartwright AN; Puerto RB; Zheng Y; Maiarana J; Freeman GJ; Wucherpfennig KW; Irvine DJ; Goldberg MS
    Nat Commun; 2017 Nov; 8(1):1747. PubMed ID: 29170511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy.
    Marciscano AE; Ghasemzadeh A; Nirschl TR; Theodros D; Kochel CM; Francica BJ; Muroyama Y; Anders RA; Sharabi AB; Velarde E; Mao W; Chaudhary KR; Chaimowitz MG; Wong J; Selby MJ; Thudium KB; Korman AJ; Ulmert D; Thorek DLJ; DeWeese TL; Drake CG
    Clin Cancer Res; 2018 Oct; 24(20):5058-5071. PubMed ID: 29898992
    [No Abstract]   [Full Text] [Related]  

  • 12. PD-1 blockade enhances radio-immunotherapy efficacy in murine tumor models.
    Zhuang Y; Li S; Wang H; Pi J; Xing Y; Li G
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):1909-1920. PubMed ID: 30074066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local Interleukin-12 Treatment Enhances the Efficacy of Radiation Therapy by Overcoming Radiation-Induced Immune Suppression.
    Yu CF; Chang CH; Wang CC; Hong JH; Chiang CS; Chen FH
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity.
    Lugade AA; Sorensen EW; Gerber SA; Moran JP; Frelinger JG; Lord EM
    J Immunol; 2008 Mar; 180(5):3132-9. PubMed ID: 18292536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of programmed death-1 pathway rescues the effector function of tumor-infiltrating T cells and enhances the antitumor efficacy of lentivector immunization.
    Zhou Q; Xiao H; Liu Y; Peng Y; Hong Y; Yagita H; Chandler P; Munn DH; Mellor A; Fu N; He Y
    J Immunol; 2010 Nov; 185(9):5082-92. PubMed ID: 20926790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of LIGHT/TNFSF14 combined with vaccination against human papillomavirus Type 16 E7 induces significant tumor regression.
    Kanodia S; Da Silva DM; Karamanukyan T; Bogaert L; Fu YX; Kast WM
    Cancer Res; 2010 May; 70(10):3955-64. PubMed ID: 20460520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel co-culture assay to assess anti-tumor CD8
    Olivo Pimentel V; Yaromina A; Marcus D; Dubois LJ; Lambin P
    J Immunol Methods; 2020 Dec; 487():112899. PubMed ID: 33068606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cells.
    Conroy H; Galvin KC; Higgins SC; Mills KH
    Cancer Immunol Immunother; 2012 Mar; 61(3):425-31. PubMed ID: 22193988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration.
    Oweida A; Hararah MK; Phan A; Binder D; Bhatia S; Lennon S; Bukkapatnam S; Van Court B; Uyanga N; Darragh L; Kim HM; Raben D; Tan AC; Heasley L; Clambey E; Nemenoff R; Karam SD
    Clin Cancer Res; 2018 Nov; 24(21):5368-5380. PubMed ID: 30042205
    [No Abstract]   [Full Text] [Related]  

  • 20. Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment.
    Darragh LB; Oweida AJ; Karam SD
    Front Immunol; 2018; 9():3154. PubMed ID: 30766539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.